US20080050442A1 - Nasal pharmaceutical formulations and methods of using the same - Google Patents

Nasal pharmaceutical formulations and methods of using the same Download PDF

Info

Publication number
US20080050442A1
US20080050442A1 US11/931,380 US93138007A US2008050442A1 US 20080050442 A1 US20080050442 A1 US 20080050442A1 US 93138007 A US93138007 A US 93138007A US 2008050442 A1 US2008050442 A1 US 2008050442A1
Authority
US
United States
Prior art keywords
particle size
microns
less
drug substance
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/931,380
Inventor
Imtiaz Chaudry
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mylan Specialty LP
Original Assignee
Dey Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US10/414,682 priority Critical patent/US9808471B2/en
Application filed by Dey Laboratories Inc filed Critical Dey Laboratories Inc
Priority to US11/931,380 priority patent/US20080050442A1/en
Publication of US20080050442A1 publication Critical patent/US20080050442A1/en
Assigned to JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT reassignment JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT SECURITY AGREEMENT Assignors: DEY PHARMA, L.P., DEY, INC., MYLAN INC., MYLAN PHARMACEUTICALS INC., MYLAN TECHNOLOGIES, INC.
Assigned to MYLAN PHARMACEUTICALS, INC., MYLAN INC., DEY PHARMA, L.P. (F/K/A DEY, L.P.), MYLAN TECHNOLOGIES, INC. reassignment MYLAN PHARMACEUTICALS, INC. PATENT RELEASE Assignors: JPMORGAN CHASE BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Assigned to BANK OF AMERICA, N.A., AS COLLATERAL AGENT reassignment BANK OF AMERICA, N.A., AS COLLATERAL AGENT SECURITY AGREEMENT Assignors: DEY PHARMA, L.P. (F/K/A DEY L.P.), MYLAN BERTEK PHARMACEUTICALS INC., MYLAN INSTITUTIONAL INC. (F/K/A UDL LABORATORIES, INC.), MYLAN PHARMACEUTICALS, INC., MYLAN TECHNOLOGIES, INC., SOMERSET PHARMACEUTICALS, INC.
Assigned to DEY, L.P. reassignment DEY, L.P. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CHAUDRY, IMTIAZ, PHD
Assigned to DEY PHARMA, L.P. reassignment DEY PHARMA, L.P. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: DEY, L.P.
Assigned to MYLAN TECHNOLOGIES, INC., MYLAN INC., MYLAN PHARMACEUTICALS, INC., MYLAN BERTEK PHARMACEUTICALS INC., SOMERSET PHARMACEUTICALS, INC., DEY PHARMA L.P. (F/K/A DEY, L.P.), MYLAN INSTITUTIONAL INC. (F/K/A UDL LABORATORIES, INC.) reassignment MYLAN TECHNOLOGIES, INC. PATENT RELEASE Assignors: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Assigned to MYLAN SPECIALTY L.P. reassignment MYLAN SPECIALTY L.P. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: DEY PHARMA, L.P.
Application status is Abandoned legal-status Critical

Links